Search Results - "Zapf, Jim"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    ViruClear: Molecularly designed biomimetic nanosponges for prevention and treatment of SARS‐CoV‐2 infections in COVID‐19 patients by Esmaeli‐Azad, Babak, Federico, Isabella, Rojas, Fernando, Zapf, Jim

    Published in The FASEB journal (01-05-2021)
    “…The current COVID‐19 pandemic infectious disease agent SARS‐CoV‐2, like its’ cousin SARS‐CoV, uses a variety of entry receptors including angiotensin…”
    Get full text
    Journal Article
  2. 2

    A human stem cell phenotypic drug screening assay for identification of opioid and non‐opioid analgesics with lowered risk of addiction by Esmaeli‐Azad, Babak, Federico, Niksha, Rojas, Fernando, Zapf, Jim

    Published in The FASEB journal (01-05-2021)
    “…Mu opioid receptors, a subclass of G protein‐coupled receptors (GPCRs), are involved in the control of pain perception and reward properties. They are also the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease by Fitzpatrick, Leo R., Small, Jeff, O’Connell, Robert, Talbott, George, Alton, Gordon, Zapf, Jim

    Published in Inflammopharmacology (01-04-2020)
    “…Introduction Retinoic Acid Related Orphan Nuclear Receptor gamma T (RORγT) is a lineage specifying transcription factor for IL-17 expressing cells, which may…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8